Dynamic gain and loss of synapses is fundamental to healthy brain function. While
Alzheimer's Disease (AD) treatment strategies have largely focussed on beta-amyloid and …

Alzheimer's disease, the most prevalent form of dementia in the elderly, is characterized by
progressive memory loss and cognitive dysfunction. It has become increasingly clear that …

Extensive neuropathological studies have established a compelling link between
abnormalities in structure and function of subcortical monoaminergic (MA-ergic) systems …

Alzheimer's disease (AD) and major depressive disorder (MDD) are highly prevalent
neuropsychiatric conditions with intriguing epidemiological overlaps. Depressed patients …

The purpose of this study is to study the neuroprotective role of selective serotonin reuptake
inhibitor (SSRI), citalopram, against Alzheimer's disease (AD). Multiple SSRIs, including …

Background There is growing availability of novel psychoactive substances (NPS), including
cognitive enhancers (CEs) which can be used in the treatment of certain mental health …

Abstract Background/Aims: Many compounds that have already been approved for alternate
diagnoses have been studied in relation to Alzheimer's disease (AD). The purpose of this …

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common
neurodegenerative disorders and exact a burden on our society greater than cardiovascular …

Alzheimer's Disease (AD) represents a complex interplay of neurological pathways and
molecular mechanisms, with significant impacts on patients' lives. This review synthesizes …

Alzheimer's disease (AD) is the most common cause of dementia and represents one of the
highest unmet needs in medicine today. Drug development efforts for AD have been …